Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Hormone Therapy
  •  Gastrointestinal Cancer
  •  Blood Cancer
  •  Haemato-Oncology
  •  Head and Neck Oncology
  •  Cervical Cancer
  •  Breast Cancer
  •  Thoracic Oncology

Welcome

Clinics in Oncology™ (Impact Factor: 2.709*) and (ISSN 2474-1663) is an interdisciplinary and borderless journal serves as the most reputable and authoritative platform for distributing key clinical oncology research to its readers, associated with Breast Cancer, Gastrointestinal Cancer, Hematologic Malignancies, Molecular Oncology, Thoracic Cancer, Genitourinary Cancer, Head and neck Cancer, Cervical Cancer, Bladder Cancer, Colon Cancer, Colorectal Cancer, Lung Cancer, Pediatric Cancer, Ovarian Cancer, Prostate Cancer, Surgical Oncology, Pediatric Oncology, Neuro-Oncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readers include active clinical oncologists in practice, researchers, students, trainees, and allied health professionals worldwide.

Clinics in Oncology™ (Impact Factor: 2.709*) encircles a wide range of informative and advanced articles that contribute significantly to the field of oncology. The journal's scope covers various aspects of oncology research, including basic science, translational research, clinical studies, and reviews.

NLM ID

[PubMed NLM ID]

Recently Published Articles

Arachidonic Acid Induces Apoptosis Under Serum- Free Conditions by Blocking PAK1-Mediated PUMA Suppression

Ko S, Woo TG, Lee SH, Ha NC and Park BJ

 Abstract  PDF  Full Text Research Article | Open Access

Citation: Clin Oncol. 2024;9(1):2053. DOI: 10.25107/2474-1663.2053

Isorhamnetin Inhibits the Proliferation and Induces Apoptosis of Hepatocellular Carcinoma by Targeting the GSK3-β/PI3K/AKT Pathway

Liu S, Lin Y, Li H, He X, Zhang C, Lan S, Yao X, Guo W and Chen H

 Abstract  PDF  Full Text Research Article | Open Access

Citation: Clin Oncol. 2024;9(1):2052. DOI: 10.25107/2474-1663.2052

Targeted Therapy Directed Genes’ Genomic Profiling in Circulating Tumor DNA of Lung Cancer Patients

Baia L, Songa J, Zhaia J, Lia J, Lua X, Zhoua Y and Zhoua J

 Abstract  PDF  Full Text Research Article | Open Access

Citation: Clin Oncol. 2024;9(1):2051. DOI: 10.25107/2474-1663.2051

LUZP2 Inhibition Sensitizes Prostate Cancer to Chemotherapy by Suppressing RAD50

Xin L, Na-Er S, Jing-Lan H, Ping G and Xiao-Ming D

 Abstract  PDF  Full Text Research Article | Open Access

Citation: Clin Oncol. 2024;9(1):2049. DOI: 10.25107/2474-1663.2049

The Progress, Achievement and Challenge of Immunotherapy in Colorectal Cancer

Lin Yi Z and Yu Qiang L

 Abstract  PDF  Full Text Review Article | Open Access

Citation: Clin Oncol. 2024;9(1):2048. DOI: 10.25107/2474-1663.2048

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Expression of the Oncoprotein E5 from Human papillomavirus and miR-203 in Pre-Cancer Lesions and Cervical Cancer
 Abstract  PDF  Full Text
Clinical Outcome for Rectal Cancer Treated with Preoperative Chemoradiotherapy (CRT) Based on the Pathological Tumor Regression Grade (TRG)
 Abstract  PDF  Full Text
View More...